InNexus Biotechnology, Inc.
IXSBF
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Net Income | -4.15M | -5.15M | -5.78M | -6.35M | -6.07M |
| Total Depreciation and Amortization | 400.90K | 390.90K | 424.20K | 467.10K | 300.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.54M | 2.90M | 3.06M | 3.08M | 2.70M |
| Change in Net Operating Assets | 743.70K | 1.27M | 1.27M | 1.33M | 502.60K |
| Cash from Operations | -467.90K | -597.00K | -1.03M | -1.47M | -2.57M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 10.90K | 14.70K | 14.70K | 46.10K | 56.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.90K | -83.90K | -83.90K | -95.00K | 704.80K |
| Cash from Investing | -73.00K | -69.20K | -69.20K | -48.90K | 760.90K |
| Total Debt Issued | 384.70K | 561.30K | 767.70K | 1.15M | 1.83M |
| Total Debt Repaid | -31.60K | -- | -- | -- | -- |
| Issuance of Common Stock | 225.00K | 225.00K | 349.50K | 349.50K | 124.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 564.50K | 762.10K | 1.07M | 1.41M | 1.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.60K | 95.90K | -28.50K | -114.70K | -32.30K |